retatrutide new england journal of medicine An experimental drug nicknamed "Reta" produced greater weight loss than any GLP-1 currently on the market: https://bit.ly/4dQOfH7 Retatrutide vs Mounjaro: triple agonist

Is GHK-Cu a drug or supplement

According to altRx: "altRx patients typically experience 1-2 lbs per week weight loss after 4 weeks, combined with a healthy diet and exercise." The company further qualifies this statement with: "Based on average weight loss reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, alongside reduced calorie intake and increased physical activity." And the brand's qualifying language continues: "Results vary based on starting weight and program adherence

24, 2023, Ethics declarations Competing interests The authors declare no competing interests

Reported side effects include: Injection site irritation Headaches Nausea Fatigue More importantly, long-term data is limited